Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

Learn about the flu shot, COVID-19 vaccine, and our masking policy »

Stanford Health Care

Highlights of the Third International Conference on Immunotherapy in Pediatric Oncology PEDIATRIC HEMATOLOGY AND ONCOLOGY Brehm, C., Huenecke, S., Pfirrmann, V., Rossig, C., Mackall, C. L., Bollard, C. M., Gottschalk, S., Schlegel, P. G., Klingebiel, T., Bader, P. 2013; 30 (5): 349-366

Abstract

The third International Conference on Immunotherapy in Pediatric Oncology was held in Frankfurt/Main, Germany, October 1-2, 2012. Major topics of the conference included (i) cellular therapies using antigen-specific and gene-modified T cells for targeting leukemia and pediatric solid tumors; (ii) overcoming hurdles and barriers with regard to immunogenicity, immune escape, and the role of tumor microenvironment; (iii) vaccine strategies and antigen presentation; (iv) haploidentical transplantation and innate immunity; (v) the role of immune cells in allogeneic transplantation; and (vi) current antibody/immunoconjugate approaches for the treatment of pediatric malignancies. During the past decade, major advances have been made in improving the efficacy of these modalities and regulatory hurdles have been taken. Nevertheless, there is still a long way to go to fully exploit the potential of immunotherapeutic strategies to improve the cure of children and adolescents with malignancies. This and future meetings will support new collaborations and insights for further translational and clinical immunotherapy studies.

View details for DOI 10.3109/08880018.2013.802106

View details for Web of Science ID 000321772400001

View details for PubMedID 23758210